Psilocybin FCR Early-Stage Breast Cancer
Clinical trial registration, sponsored by NYU Langone Health, registered 2 Nov 2026.
Phase 2 · not yet recruiting · n = 100
Tags: Registry, Psilocybin, Depression, Anxiety, Cancer.
Newly registered at NYU: psilocybin-assisted psychotherapy for fear of recurrence in early-stage breast cancer, 25 mg versus 5 mg active placebo
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original